Trial NCT03593915

View at ClinicalTrials.gov 
Org. Study IDs: TPI-ALV-102

Last trial update was posted on 2023-11-09

MeSH Interventions

Alvocidib Azacitidine Decitabine

MeSH Conditions

Myelodysplastic Syndromes Preleukemia

Other Conditions

Myelodysplastic Syndromes (MDS)

Stopping Reasons

The sponsor decided not to continue the study based on the overall company strategy in AML.

Limitations And Caveats

A business decision was made to stop enrollment and the study was discontinued on 17 November 2020. Consistent with Food and Drug Administration and International Council for Harmonisation guidance on the content for abbreviated and synoptic CSRs, only safety data are analyzed and reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID